{
  "meta": {
    "title": "30_Disorders_Of_Menstruation",
    "url": "https://brainandscalpel.vercel.app/30-disorders-of-menstruation-3254718a.html",
    "scrapedAt": "2025-11-30T12:29:59.071Z"
  },
  "questions": [
    {
      "text": "Which of the following statements is true regarding amenorrhoea?<div class='question-desc-html'><p>MRKH -&nbsp;Mayer-Rokitansky-K&uuml;ster-Hauser&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "MRKH syndrome is associated with secondary amenorrhoea"
        },
        {
          "id": 2,
          "text": "Primary amenorrhoea is seen in Turner  syndrome"
        },
        {
          "id": 3,
          "text": "Primary amenorrhea is absence of menarche by 13 years"
        },
        {
          "id": 4,
          "text": "Secondary amenorrhea is absence of menses for 6 months"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Primary amenorrhoea is seen in Turner syndrome</p>\n<p><strong>Amenorrhoea</strong> is a<strong> symptom</strong> and not a disease entity. It refers to the <strong>absence of menstruation</strong> that can be physiological or pathological.</p>\n<p><strong>Primary</strong> amenorrhea is defined as an absence of menstruation by the <strong>age of 15 years.&nbsp;</strong>At age 13 years, if no menses have occurred and there is a complete absence of secondary sexual characteristics such as breast development, evaluation for primary amenorrhea should begin.<strong>&nbsp;</strong>Mullerian agenesis (<strong>MRKH syndrome</strong>), androgen insensitivity syndrome, and <strong>Turner syndrome</strong> present with primary amenorrhea. In Turner's syndrome,&nbsp;<strong>gonadal dysgenesis</strong>&nbsp;causes primary <strong>ovarian failure</strong>, resulting in <strong>hypogonadism</strong> and <strong>amenorrhea</strong>.</p>\n<p><strong>Secondary</strong> amenorrhea is defined as the<strong> absence of menses</strong> for <strong>3</strong>&nbsp;or more <strong>months</strong> or <strong>fewer </strong>than<strong> 9 cycles per year</strong> after the establishment of regular menstrual cycles. Polycystic ovarian syndrome and hypothyroidism are associated with secondary amenorrhea. Pregnancy is the most common physiological cause of secondary amenorrhea.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3607",
      "difficulty": "medium"
    },
    {
      "text": "While evaluating a patient with secondary amenorrhoea, you administer her estrogen and progesterone. However, withdrawal bleeding is not seen. What is the likely site of lesion here?",
      "choices": [
        {
          "id": 1,
          "text": "Pituitary"
        },
        {
          "id": 2,
          "text": "Endometrium"
        },
        {
          "id": 3,
          "text": "Ovary"
        },
        {
          "id": 4,
          "text": "Hypothalamus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>absence</strong> of <strong>withdrawal bleeding</strong> after the estrogen-progesterone challenge test points towards a <strong>local endometrial lesion.</strong></p>\n<p><strong>Estrogen&ndash;progesterone challenge test</strong>&nbsp;is indicated as an investigation in case of secondary amenorrhea. It depends on estrogen-primed endometrium being present in the uterus.&nbsp;</p>\n<p>Procedure:</p>\n<ul>\n<li>Ethinyl <strong>estradiol</strong> 0.02 mg or conjugated equine estrogen 1.25 mg is to be taken <strong>daily</strong> for<strong> 25 days.</strong></li>\n<li><strong>Medroxyprogesterone acetate</strong> 10 mg daily is added from<strong> day 15&ndash;25.</strong></li>\n<li>Alternately, one course of oral contraceptive pill is given and to observe whether withdrawal bleeding occurs or not.</li>\n</ul>\n<p>Results:</p>\n<ul>\n<li>If there is <strong>no bleeding,</strong>&nbsp;a&nbsp;<strong>local endometrial lesion&nbsp;</strong>is present such as uterine synechiae. This is to be confirmed by HSG or hysteroscopy.</li>\n<li>If <strong>withdrawal bleeding</strong> <strong>occurs</strong>, the endometrium is responsive but the endogenous estrogen production is inadequate. Hence, the <strong>defect</strong> lies in the <strong>ovary, hypothalamus, </strong>or<strong> pituitary.</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6711",
      "difficulty": "medium"
    },
    {
      "text": "The risk of Asherman syndrome is highest if D&C is done for ____.",
      "choices": [
        {
          "id": 1,
          "text": "Dysfunctional uterine bleeding"
        },
        {
          "id": 2,
          "text": "Postpartum haemorrhage"
        },
        {
          "id": 3,
          "text": "Missed abortion"
        },
        {
          "id": 4,
          "text": "Medical termination of pregnancy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The risk of developing<strong> Asherman syndrome </strong>is the highest if<strong> D&amp;C</strong> is done for <strong>postpartum hemorrhage</strong>.</p>\n<p>This is because the <strong>postpartum</strong> <strong>uterus</strong> is <strong>larger</strong> and bulkier. Hence,&nbsp;a <strong>greater area</strong> of the uterine wall is <strong>curetted</strong>. This increases the risk of developing Asherman syndrome.</p>\n<p>Asherman syndrome is the presence of <strong>uterine synechiae</strong>, due to the destruction of large areas of the endometrium. The <strong>treatment</strong> of Asherman syndrome is by <strong>hysteroscopic adhesiolysis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6946",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding oligomenorrhea?",
      "choices": [
        {
          "id": 1,
          "text": "Refers to frequent menstruation"
        },
        {
          "id": 2,
          "text": "Regularly timed episodes of bleeding"
        },
        {
          "id": 3,
          "text": "Menstruation occurring at an interval of more than 30 days"
        },
        {
          "id": 4,
          "text": "Can progress to amenorrhea"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Oligomenorrhoea</strong> can <strong>progress to</strong> develop into <strong>amenorrhoea.</strong> </p>\n<p>Oligomenorrhoea means <strong>infrequent</strong>, <strong>irregularly</strong> timed episodes of bleeding usually occurring at intervals of <strong>more than 38 days.</strong></p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3608",
      "difficulty": "medium"
    },
    {
      "text": "A patient with uterine fibroids complains of frequent menstruation with an average cycle duration of 19-21 days. What is this menstrual irregularity called?",
      "choices": [
        {
          "id": 1,
          "text": "Hypomenorrhea"
        },
        {
          "id": 2,
          "text": "Polymenorrhea"
        },
        {
          "id": 3,
          "text": "Oligomenorrhea"
        },
        {
          "id": 4,
          "text": "Menorrhagia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given case scenario is suggestive of <strong>polymenorrhoea, </strong>also known as epimenorrhea. It refers to <strong>frequent</strong> episodes of <strong>menstruation,</strong> usually occurring at intervals of <strong>21 days or less</strong>.</p>\n<p>The definitions of various menstrual cycle irregularities are:</p>\n<p><strong>Amenorrhoea</strong> refers to the absence of menstruation. </p>\n<p><strong>Intermenstrual bleeding</strong> refers to occasional episodes of bleeding (usually not excessive) that occur between otherwise normal menstrual cycles.</p>\n<p><strong>Hypomenorrhea </strong>refers to regularly timed cycles, but having scanty episodes of bleeding.</p>\n<p><strong>Menorrhagia</strong> refers to regularly timed menstrual cycles with excessive bleeding (&gt;80 mL in amount) and/or increased duration of flow (&gt;8 days).</p>\n<p><strong>Metrorrhagia</strong> refers to normal cyclical bleeding with superimposed irregularly timed episodes of bleeding.</p>\n<p><strong>Menometrorrhagia</strong> refers to excessive, prolonged bleeding that occurs at irregularly timed and frequent intervals.</p>\n<p><strong>Oligomenorrhea</strong> refers to infrequent, irregularly timed cycles with intervals of more than 38 days.</p>\n<p><strong>Precocious menstruation</strong> refers to the occurrence of menstruation before the age of 10 years.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3609",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is true regarding menorrhagia?",
      "choices": [
        {
          "id": 1,
          "text": "Heavy and regularly timed episodes of bleeding"
        },
        {
          "id": 2,
          "text": "Coagulation studies are routinely performed"
        },
        {
          "id": 3,
          "text": "Amount of bleeding greater than 50 ml"
        },
        {
          "id": 4,
          "text": "Duration of bleeding greater than 5 days"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Menorrhagia</strong> is defined as <strong>heavy</strong> but <strong>regular</strong> menstrual bleeding.</p>\n<p>Menorrhagia denotes regularly timed episodes of bleeding that are <strong>excessive </strong>in<strong> amount </strong>(<strong>&gt;80 mL</strong>) and/or<strong> duration </strong>of flow (<strong>&gt;8 days</strong>).<strong>&nbsp;</strong>Nowadays, menorrhagia has been replaced by the term <strong>heavy menstrual bleeding</strong>. This is defined as <strong>greater than 80 mL per cycle</strong>, which will result in anemia if recurrent</p>\n<p>Investigations done in case of menorrhagia:</p>\n<ul>\n<li>Complete blood count (CBC) - to rule out anemia and thrombocytopenia.</li>\n<li><strong>Coagulation studies</strong> are ordered <strong>only</strong> <strong>in</strong> case of<strong> clinical suspicion</strong> and correlation with CBC</li>\n<li>Sonohysterography/Hysteroscopy - to diagnose endometrial polyps and fibroids</li>\n<li>Endometrial biopsy - in case of suspected endometrial hyperplasia</li>\n<li>Transvaginal ultrasound - supplements biopsy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3610",
      "difficulty": "easy"
    },
    {
      "text": "A 33-year-old female patient comes with complaints of menorrhagia for the past 3 months. The duration and regularity of her menstrual cycles are normal. Non-hormonal management has been tried without success. What is the most appropriate next step?",
      "choices": [
        {
          "id": 1,
          "text": "Uterine artery embolisation"
        },
        {
          "id": 2,
          "text": "Endometrial ablation"
        },
        {
          "id": 3,
          "text": "Hormonal therapy"
        },
        {
          "id": 4,
          "text": "Hysterectomy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hormonal therapy</strong> is the next best step in the given scenario of <strong>menorrhagia</strong> that is <strong>unresponsive to non-hormonal</strong> therapy.&nbsp;</p>\n<p><strong>Menorrhagia/heavy menstrual bleeding</strong>&nbsp;is defined as&nbsp;<strong>heavy</strong>&nbsp;but&nbsp;<strong>regular</strong>&nbsp;menstrual bleeding, &gt;80mL of blood loss, or &gt;8 days of bleeding per menstrual period. It&nbsp;can be acute (&lt;6 months) or chronic (&gt;6 months).</p>\n<p>It is managed as follows:</p>\n<ul>\n<li><strong>Medical</strong> - <strong>first line</strong> of treatment.&nbsp;&nbsp;\n<ul>\n<li>NSAIDs</li>\n<li>Tranexamic acid&nbsp;&nbsp;</li>\n<li><strong>OCPs/progestogens</strong> - if non-hormonal management fails&nbsp;</li>\n<li>Mirena IUCD</li>\n<li>GnRH agonists</li>\n<li>Blood transfusion, if required&nbsp;</li>\n</ul>\n</li>\n<li><strong>Surgical</strong> - if medical management fails, depending on the diagnosis:\n<ul>\n<li><strong>Endometrial ablation</strong>&nbsp;- hysteroscopic, TCRE, RITEA, microwave, NovaSure, etc (option B)</li>\n<li><strong>Uterine artery embolization </strong>(option A)</li>\n<li>Uterine tamponade</li>\n<li><strong>Hysterectomy</strong> - if all minimally invasive methods fail (option D)</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0749",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a feature of menometrorrhagia?",
      "choices": [
        {
          "id": 1,
          "text": "Excessive bleeding"
        },
        {
          "id": 2,
          "text": "Prolonged bleeding"
        },
        {
          "id": 3,
          "text": "Irregularly timed bleeding"
        },
        {
          "id": 4,
          "text": "Infrequent bleeding"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Menometrorrhagia</strong> refers to menstrual bleeding at <strong>frequent intervals</strong>.</p>\n<p>Menometrorrhagia means <strong>excessive, prolonged</strong> bleed&shy;ing that occurs at <strong>irregularly timed</strong> and frequent intervals. It can be caused by cervical cancer and granulosa cell tumors.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3612",
      "difficulty": "medium"
    },
    {
      "text": "A patient who had undergone a dilatation and curettage procedure comes to the clinic 6 months later for a follow-up visit. She informs you that since the procedure, she has had scanty blood loss during menses which only lasts for 1-2 days. What is this pattern of bleeding called?",
      "choices": [
        {
          "id": 1,
          "text": "Oligomenorrhea"
        },
        {
          "id": 2,
          "text": "Polymenorrhea"
        },
        {
          "id": 3,
          "text": "Epimenorrhea"
        },
        {
          "id": 4,
          "text": "Hypomenorrhea"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given clinical scenario, the pattern of bleeding is called <strong>hypomenorrhea.</strong> Hypomenorrhea along with a prior history of dilatation and curettage are suggestive of <strong>partial Asherman's syndrome.</strong></p>\n<p>Hypomenorrhoea refers to <strong>regularly timed</strong> but <strong>scanty episodes</strong> of bleeding. It can be seen in:</p>\n<ul>\n<li>Partial Asherman's syndrome - uterine synechiae, causing scarring</li>\n<li>Oral contraceptive use&nbsp;</li>\n<li>Perimenopausal age group&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3613",
      "difficulty": "easy"
    },
    {
      "text": "A 36-year-old woman presents to the gynecology OPD with complaints of occasional bleeding PV between her usual menstrual cycles. Which of the following is true about her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Bleeding is always pathological"
        },
        {
          "id": 2,
          "text": "Bleeding is usually scanty"
        },
        {
          "id": 3,
          "text": "Occurs between 2 abnormal cycles"
        },
        {
          "id": 4,
          "text": "Occurs in consecutive cycles"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given case scenario is suggestive of <strong>intermenstrual bleeding</strong>, also known as metrorrhagia. Usually, this is <strong>scanty,</strong> and&nbsp;not excessive.&nbsp;</p>\n<p>Intermenstrual bleeding or <strong>metrorrhagia</strong> refers to <strong>irregularly timed</strong> episodes of bleeding superimposed on <strong>normal cyclical bleeding</strong>. It can be caused by:</p>\n<ul>\n<li><strong>Ovulation (physiological)</strong></li>\n<li>Polyps</li>\n<li>Cervical cancer</li>\n<li>Lower genital tract infections etc.&nbsp;</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3614",
      "difficulty": "medium"
    },
    {
      "text": "A young girl with McCune-Albright syndrome is noted to have precocious menstruation. This condition is defined as the occurrence of menstruation at____.",
      "choices": [
        {
          "id": 1,
          "text": "<8 years"
        },
        {
          "id": 2,
          "text": "<7 years"
        },
        {
          "id": 3,
          "text": "<10 years"
        },
        {
          "id": 4,
          "text": "<11 years"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Precocious menstruation</strong>&nbsp;refers to the occurrence of menstruation <strong>before</strong> the age of <strong>10 years</strong>.<strong>&nbsp;</strong></p>\n<p><strong>Precocious puberty</strong>&nbsp;in a girl is the appearance of any of the <strong>secondary sexual characteristics</strong> before the age of <strong>8 years</strong> or the occurrence of <strong>menarche</strong> before the age of <strong>10 years</strong>.</p>\n<p><strong>McCune Albright</strong> syndrome is&nbsp;associated with <strong>cafe-au-lait spots</strong>, <strong>precocious puberty</strong> (and precocious menstruation), and <strong>polyostotic fibrous dysplasia</strong> leading to&nbsp;recurrent fractures. The image given below shows cafe-au-lait spots.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1fb4d5d4b9a94208b076b5b4e2fca638x145x240.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3615",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old woman presents with profuse, painless vaginal bleeding. She has a history of 6-8 weeks of amenorrhea and her UPT is negative. On ultrasound, endometrial thickness is 21mm. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Senile endometritis"
        },
        {
          "id": 2,
          "text": "Halban disease"
        },
        {
          "id": 3,
          "text": "Metropathia haemorrhagica"
        },
        {
          "id": 4,
          "text": "Endometriosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given case scenario is suggestive of <strong>metropathia hemorrhagica.</strong>&nbsp;</p>\n<p>Metropathia hemorrhagica is a form of anovulatory abnormal uterine bleeding. It is characterized by&nbsp;<strong>continuous painless vaginal bleeding</strong> at the onset of menses or <strong>preceded by</strong> a <strong>6-8 week</strong> period of <strong>amenorrhea</strong>. It is usually seen in the age group of&nbsp;<strong>40-45 years</strong>. A history of menorrhagia may be present.&nbsp;</p>\n<p>On examination, the uterus is bulky and uniformly enlarged. Histopathological findings are:</p>\n<ul>\n<li><strong>Myohyperplasia</strong> of the uterine wall - up to 2.5cm</li>\n<li>Thick endometrium with cystic glandular hyperplasia appearing as <strong>swiss cheese pattern</strong></li>\n<li><strong>Absence</strong> of <strong>secretory endometrium</strong> i.e absence of corkscrew glands&nbsp;</li>\n<li>Thin, slender endometrial <strong>polyps</strong> project into the uterine cavity</li>\n<li>Corpus luteum is absent</li>\n<li>One or both ovaries may contain a cyst</li>\n</ul>\n<p>Option A: <strong>Senile endometritis</strong> occurs after menopause when the <strong>endometrium</strong> is <strong>thin</strong> and <strong>atrophic</strong>. It may be associated with accumulation of pus in the uterine cavity.&nbsp;</p>\n<p>Option B: <strong>Halban's disease</strong> is irregular shedding and is due to <strong>persistent corpus luteum</strong>. Regular cycles with prolonged bleeding and normal flow is present.&nbsp;</p>\n<p>Option D:<strong> Endometriosis</strong> usually presents in the <strong>reproductive age</strong> group, with symptoms of menorrhagia, <strong>dysmenorrhea</strong> and chronic pelvic pain.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6961",
      "difficulty": "medium"
    },
    {
      "text": "Which does 'I' stand for in the PALM-COEIN classification for abnormal uterine bleeding?",
      "choices": [
        {
          "id": 1,
          "text": "Infectious causes"
        },
        {
          "id": 2,
          "text": "Iatrogenic causes"
        },
        {
          "id": 3,
          "text": "Idiopathic bleeding"
        },
        {
          "id": 4,
          "text": "Inflammatory causes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The 'I' in the FIGO<strong> PALM-COEIN</strong> classification for <strong>abnormal uterine bleeding</strong> (AUB) stands for<strong> iatrogenic</strong> causes.</p>\n<div class=\"page\" title=\"Page 353\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>AUB</strong> in the <strong>reproductive age group</strong> was previously known as <strong>dysfunctional uterine bleeding,</strong> however, that term is now <strong>obsolete.</strong> AUB can be acute or chronic:</p>\n<ul>\n<li>Acute AUB - it can start sporadically or be superimposed on chronic AUB.</li>\n<li>Chronic AUB - it lasts for 3-6 months minimum.</li>\n</ul>\n<p><strong>PALM-COEIN classification of AUB:</strong></p>\n<ul>\n<li>Polyp (AUB-P):\n<ul>\n<li>Endometrial polyps</li>\n<li>Endocervical polyps</li>\n</ul>\n</li>\n<li>Adenomyosis (AUB-A)</li>\n<li>Leiomyoma (AUB-L). Fibroids are further classified as:\n<ul>\n<li>Submucosal (SM)</li>\n<li>Other (O)</li>\n</ul>\n</li>\n<li>Malignancy and hyperplasia (AUB-M)&nbsp;\n<ul>\n<li>Endometrial hyperplasia&nbsp;</li>\n<li>Endometrial carcinoma</li>\n</ul>\n</li>\n<li>Coagulopathy (AUB-C)\n<ul>\n<li>von Willebrand's disease</li>\n<li>Hemophilias</li>\n</ul>\n</li>\n<li>Ovarian causes (AUB-O)\n<ul>\n<li>PCOD</li>\n<li>Hypothyroidism</li>\n<li>Hyperprolactinemia.&nbsp;&nbsp;</li>\n</ul>\n</li>\n<li>Endometrial causes (AUB-E)\n<ul>\n<li>Tubercular or chlamydial endometritis&nbsp;</li>\n</ul>\n</li>\n<li>Iatrogenic causes (AUB-I)\n<ul>\n<li>Intrauterine contraceptive devices</li>\n<li>Anticoagulants</li>\n<li>Tricyclic antidepressants</li>\n</ul>\n</li>\n<li>Not yet classified (AUB-N) includes rare causes such as\n<ul>\n<li>Arteriovenous malformations&nbsp;</li>\n<li>Myometrial hypertrophy&nbsp;</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0094",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old P1L1 woman presented with heavy menstrual bleeding and occasional spotting between cycles. What is the first investigation to be done for her?",
      "choices": [
        {
          "id": 1,
          "text": "Ultrasound abdomen"
        },
        {
          "id": 2,
          "text": "Pap smear"
        },
        {
          "id": 3,
          "text": "Urine beta-hCG"
        },
        {
          "id": 4,
          "text": "Transvaginal ultrasound"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The first investigation to be done in a case of abnormal uterine bleeding <strong>(AUB)</strong> in the <strong>reproductive age</strong> group is <strong>u</strong><strong>rine β-hCG </strong>estimation. This is done to rule out pregnancy.</p>\n<div class=\"page\" title=\"Page 207\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 208\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In the <strong>reproductive age group</strong>, anovulatory uterine bleeding is encountered less often. Therefore, pregnancy must be excluded. Pregnancy complications such as <strong>miscarriage, ectopic</strong> <strong>pregnancies</strong>, and <strong>molar</strong> <strong>pregnancies</strong> may present with <strong>AUB</strong>, hence these need to be ruled out by urine β-hCG<strong> </strong>levels. This is done for all women in the reproductive age group. </p>\n<p>Other investigations to be done for AUB are:</p>\n<ul>\n<li><strong>Pap smear</strong> - to rule out cervical cancer and preinvasive lesions (CIN).</li>\n<li><strong>Transabdominal ultrasound</strong> - to visualize the pelvic organs and lesions such as endometrial hyperplasia, polyps, fibroids, etc.</li>\n<li><strong>Transvaginal ultrasound</strong> - to visualize the pelvic organs. It is done after evaluating β-hCG. This is more comfortable for a patient compared to a transabdominal ultrasound as it doesn't require a full bladder. </li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0096",
      "difficulty": "hard"
    },
    {
      "text": "A woman with AUB-E, who was unresponsive to medical management, underwent a hysteroscopic ablation. Which of the following is false about this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Safe, effective with less morbidity"
        },
        {
          "id": 2,
          "text": "Quicker recovery"
        },
        {
          "id": 3,
          "text": "Fertility is preserved"
        },
        {
          "id": 4,
          "text": "Method destroys 2-3 mm of myometrium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Fertility</strong> is<strong> not preserved</strong> with ablative procedures, because the <strong>endometrium</strong> and superficial <strong>myometrium</strong> are <strong>destroyed</strong>.</p>\n<p>In ablative procedures, the <strong>uterus</strong> is <strong>preserved</strong>, and hysterectomy is avoided. The endometrium along with 2-3mm of superficial myometrium is destroyed.</p>\n<p>Various <strong>methods of endometrial ablation</strong> include:</p>\n<ul>\n<li>Hysteroscopic endometrial ablation</li>\n<li>Transcervical endometrial resection (TCRE) - now replaced by bipolar electrode called Versapoint</li>\n<li>Radiofrequency induced thermal ablation (RITEA)</li>\n<li>Microwave ablation</li>\n<li>NovaSure -&nbsp;impedance-controlled endometrial ablation</li>\n<li>Bilateral uterine artery embolization</li>\n<li>Uterine tamponade</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0097",
      "difficulty": "medium"
    },
    {
      "text": "When is dilatation and curettage contraindicated?",
      "choices": [
        {
          "id": 1,
          "text": "Pelvic inflammatory disease"
        },
        {
          "id": 2,
          "text": "Ectopic pregnancy"
        },
        {
          "id": 3,
          "text": "Menstrual irregularities"
        },
        {
          "id": 4,
          "text": "Endometriosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Dilatation and curettage (D&amp;C) is contraindicated in <strong>pelvic inflammatory disease</strong>&nbsp;(PID) as it increases the risk of ascending genital infection.</p>\n<p>D&amp;C is a minor gynecological procedure of dilating the cervix and curetting the endometrial tissue from the uterine cavity. Diagnostic indications of D&amp;C include AUB, secondary amenorrhea&nbsp;to detect tubercular endometritis, postmenopausal bleeding to rule out endometrial cancer or hyperplasia, and infertility due to genital TB.</p>\n<p>Therapeutic indications of D&amp;C include missed abortion, incomplete abortion, retained products of conception, and endometrial polypectomy.</p>\n<p><strong>Absolute contraindication</strong> of D&amp;C includes&nbsp;Suspected/ desired <strong>pregnancy</strong> and <strong>lower genital</strong> tract <strong>infection.</strong> However, D&amp;C is performed in some cases with genital infections like septic abortion (where retained pieces of placenta act as a nidus and need to be removed) and pyometra (as there is cervical obstruction with superinfection of menstrual blood and cellular debris, D&amp;C is appropriate to remove the obstruction as well as the source of infection)</p>\n<p>Complications of D&amp;C include ascending infection, cervical tear with bleeding, incompetent os, uterine perforation, and ashermann syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b93a57fa46a74483919fa882c10bc6f1x1280x4487.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4455",
      "difficulty": "easy"
    },
    {
      "text": "A 31-year-old woman presented with acute abdominal pain and spotting. UPT was negative. On examination, she was tachycardic and afebrile. Guarding and abdominal tenderness was present. CT abdomen showed air in the uterine wall and pneumoperitoneum. Which of the following is her condition most likely to be a complication of?",
      "choices": [
        {
          "id": 1,
          "text": "Endometrial biopsy"
        },
        {
          "id": 2,
          "text": "Dilatation and curettage"
        },
        {
          "id": 3,
          "text": "Laparoscopy"
        },
        {
          "id": 4,
          "text": "Hysteroscopy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given case scenario is suggestive of <strong>uterine perforation</strong>. In a<strong> non-pregnant uterus,</strong> uterine perforation is most likely to occur due to <strong>dilatation and curettage. </strong></p>\n<p>In <strong>pregnancy</strong> and <strong>uterine malignancies,</strong> the uterus is soft. Hence, <strong>uterine perforation is common </strong>during surgeries. </p>\n<p>The etiology of uterine perforation is as follows:</p>\n<ul>\n<li>Insertion of <strong>intrauterine contraceptive devices </strong>(IUCD)<strong>- </strong>due to the lack of provider experience.</li>\n<li>Spontaneous migration of IUCD within the myometrium</li>\n<li><strong>Dilatation and curettage (D&amp;C)</strong></li>\n<li>Hysteroscopy - diagnostic (e.g, hysteroscopic biopsy) or therapeutic (adhesiolysis) </li>\n<li>Laparoscopy</li>\n</ul>\n<p>It can present with <strong>fever,</strong> acute abdominal <strong>pain,</strong> nausea and vomiting, and <strong>bleeding</strong> pv. Imaging reveals air within the uterine wall or <strong>pneumoperitoneum.</strong>  </p>\n<p>The management is as follows:</p>\n<ul>\n<li><strong>Conservative</strong> management - <strong>Fundal injuries</strong> are managed conservatively, as the myometrium contracts around the defect.</li>\n<li>Surgical management:\n<ul>\n<li>Small defects can be repaired laparoscopically or hysteroscopically.</li>\n<li>Emergency <strong>laparotomy</strong> - as abdominal viscera may prolapse through the defect. </li>\n<li><strong>Hysterectomy</strong> - if the defect is large, and the patient has completed her family, hysterectomy is done as last resort.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3120",
      "difficulty": "medium"
    },
    {
      "text": "An 18-year-old girl presents to you with cramping abdominal pain. It starts at the onset of menses and is more pronounced in the first two days. Which condition is she likely suffering from?",
      "choices": [
        {
          "id": 1,
          "text": "Congestive dysmenorrhoea"
        },
        {
          "id": 2,
          "text": "Spasmodic dysmenorrhoea"
        },
        {
          "id": 3,
          "text": "Unilateral dysmenorrhoea"
        },
        {
          "id": 4,
          "text": "Acquired dysmenorrhoea"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given case scenario is suggestive of <strong>s</strong><strong>pasmodic dysmenorrhea.</strong>&nbsp;It<strong>&nbsp;</strong>presents with <strong>cramping pain</strong> at the <strong>onset of menses</strong> which is more pronounced in the first two days of menstruation.</p>\n<p><strong>Dysmenorrhoea</strong> is defined as <strong>cramping pain </strong>accompanying <strong>menstruation</strong>. It can be classified as follows:</p>\n<p>A. Etiological classification:</p>\n<ul>\n<li><strong>Primary</strong> dysmenorrhoea - no identifiable pelvic pathology. Commonly occurs in the age group of 18 to 25 years, with ovulatory cycles.</li>\n<li><strong>Secondary (acquired)</strong> dysmenorrhoea - is associated with <strong>pelvic pathologies</strong> such as fibroids, adenomyosis, PID, and endometriosis.</li>\n</ul>\n<p><strong>Unilateral</strong> <strong>dysmenorrhoea</strong> can occur in a rudimentary horn of a <strong>bicornuate</strong> uterus, <strong>IUCD</strong> users, and <strong>cervical stenosis.</strong></p>\n<p>B. Clinical classification:</p>\n<ul>\n<li><strong>Spasmodic dysmenorrhoea:</strong>\n<ul>\n<li>Most prevalent&nbsp;</li>\n<li>Cramping pain at the onset of menses, more pronounced on the first 2 days.&nbsp;</li>\n<li>Occurs due to myometrial contractions due to increased PGF2&alpha;</li>\n<li>Common in adolescents and young women</li>\n</ul>\n</li>\n<li><strong>Congestive dysmenorrhoea</strong>:\n<ul>\n<li>Pelvic pain and pelvic discomfort occurs, a&nbsp;few days before menses begin</li>\n<li>Occurs due to pelvic venous congestion</li>\n<li>Seen in pelvic endometriosis, PID, fibroids, and IUCD users</li>\n</ul>\n</li>\n<li><strong>Membranous dysmenorrhoea</strong>:\n<ul>\n<li>Least prevalent&nbsp;</li>\n<li>The endometrium is shed as a cast&nbsp;at the time of menstruation</li>\n<li>The passage of the cast is associated with painful uterine cramps</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6971",
      "difficulty": "easy"
    },
    {
      "text": "An increase in which of the following is spasmodic pain during dysmenorrhoea attributed to?",
      "choices": [
        {
          "id": 1,
          "text": "PGE1"
        },
        {
          "id": 2,
          "text": "PGE2"
        },
        {
          "id": 3,
          "text": "PGD2"
        },
        {
          "id": 4,
          "text": "PGF2α"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Spasmodic pain</strong> is attributed to myometrial contractions occuring due to<strong> increased PGF2&alpha;.</strong>&nbsp;This is secreted under the effect of<strong> pr</strong><strong>ogesterone.</strong></p>\n<p>Progesterone is secreted after ovulation by the corpus luteum. Hence, in <strong>anovulatory</strong> <strong>cycles</strong>,&nbsp;menstruation is <strong>not accompanied by spasmodic pain.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6972",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old woman presents to the psychiatry OPD with complaints of mood swings and depression 10 days prior to her menses. This is associated with fatigue, breast tenderness, and bloating. Her symptoms resolve once menses begin. What is the treatment of choice in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Evening primrose oil"
        },
        {
          "id": 2,
          "text": "Leuprolide"
        },
        {
          "id": 3,
          "text": "Fluoxetine"
        },
        {
          "id": 4,
          "text": "Drospirenone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given case scenario is suggestive of <strong>premenstrual dysphoric disorder</strong> (PMDD). Selective serotonin reuptake inhibitors (<strong>SSRIs</strong>) such as <strong>fluoxetine</strong>, sertraline, and paroxetine are the treatment of choice for PMDD.&nbsp;</p>\n<p>DSM-5 defines<strong> premenstrual dysphoric disorder&nbsp;</strong>(PMDD) as the presence of <strong>at least five</strong> of the associated<strong> symptoms</strong> most of the time during the<strong> premenstrual week.&nbsp;</strong>Symptoms&nbsp;improve within a few days after&nbsp;menses and are minimal in the postmenstrual period. These symptoms include:</p>\n<ul>\n<li>Marked <strong>emotional lability</strong>&nbsp;</li>\n<li>Marked irritability or anger</li>\n<li>Marked <strong>depressive</strong> mood, self-deprecating thoughts&nbsp;</li>\n<li>Marked anxiety</li>\n<li>Decreased interest in activities</li>\n<li>Difficulty in concentration</li>\n<li><strong>Lethargy</strong></li>\n<li>Appetite changes</li>\n<li><strong>Bloating</strong></li>\n<li><strong>Breast tenderness</strong></li>\n<li>Weight gain&nbsp;</li>\n</ul>\n<div class=\"page\" title=\"Page 1209\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&nbsp;Treatment of PMDD is as follows:</p>\n<ul>\n<li><strong>Lifestyle</strong> <strong>changes</strong> such as - stress reduction, adequate sleep, and exercise, reduction in caffeine intake, smoking cessation</li>\n<li>Selective serotonin reuptake inhibitors (<strong>SSRIs</strong>) - fluoxetine, paroxetine, sertraline&nbsp;</li>\n<li><strong>Evening primrose oil</strong> - to treat breast tenderness</li>\n<li>Ovulation suppression - danazol, <strong>leuprolide, drospirenone</strong></li>\n<li>Other less proven methods - cognitive behavioral therapy, calcium supplements, etc.&nbsp;</li>\n</ul>\n<p>Note: Premenstrual syndrome has no scientific definition. The constellation of symptoms is now defined under PMDD.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6974",
      "difficulty": "medium"
    }
  ]
}